• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症与癌症:分子机制及临床后果

Inflammation and cancer: molecular mechanisms and clinical consequences.

作者信息

Akkız Hikmet, Şimşek Halis, Balcı Deniz, Ülger Yakup, Onan Engin, Akçaer Nevin, Delik Anıl

机构信息

Department of Gastroenterology, Medical Faculty, Bahçeşehir University, İstanbul, Türkiye.

Department of Gastroenterology, Medical Faculty, Hacettepe University, Ankara, Türkiye.

出版信息

Front Oncol. 2025 Mar 17;15:1564572. doi: 10.3389/fonc.2025.1564572. eCollection 2025.

DOI:10.3389/fonc.2025.1564572
PMID:40165901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11955699/
Abstract

Inflammation, a hallmark of cancer, has been associated with tumor progression, transition into malignant phenotype and efficacy of anticancer treatments in cancer. It affects all stages of cancer, from the initiation of carcinogenesis to metastasis. Chronic inflammation induces immunosup-pression, providing an environment conducive to carcinogenesis, whereas acute inflammation induces an antitumor immune response, leading to tumor suppression. Solid tumors have an inflammatory tumor microenvironment (TME) containing cancer cells, immune cells, stromal cells, and soluble molecules, which plays a key role in tumor progression and therapy response. Both cancer cells and stromal cells in the TME are highly plastic and constantly change their phenotypic and functional properties. Cancer-associated inflammation, the majority of which consists of innate immune cells, plays an important role in cancer cell plasticity, cancer progression and the development of anticancer drug resistance. Today, with the combined used of advanced technologies, such as single-cell RNA sequencing and spatial molecular imaging analysis, the pathways linking chronic inflammation to cancer have been largely elucidated. In this review article, we highlighted the molecular and cellular mechanisms involved in cancer-associated inflammation and its effects on cancer progression and treatment response. We also comprehensively review the mechanisms linking chronic inflammation to cancer in the setting of GI cancers.

摘要

炎症是癌症的一个标志,与肿瘤进展、向恶性表型的转变以及癌症中抗癌治疗的疗效相关。它影响癌症的各个阶段,从致癌作用的起始到转移。慢性炎症诱导免疫抑制,提供有利于致癌作用的环境,而急性炎症诱导抗肿瘤免疫反应,导致肿瘤抑制。实体瘤具有包含癌细胞、免疫细胞、基质细胞和可溶性分子的炎性肿瘤微环境(TME),其在肿瘤进展和治疗反应中起关键作用。TME中的癌细胞和基质细胞都具有高度可塑性,并不断改变其表型和功能特性。癌症相关炎症在癌细胞可塑性、癌症进展和抗癌耐药性的发展中起重要作用,其中大部分由先天免疫细胞组成。如今,随着单细胞RNA测序和空间分子成像分析等先进技术的联合应用,将慢性炎症与癌症联系起来的途径已在很大程度上得到阐明。在这篇综述文章中,我们重点介绍了癌症相关炎症所涉及的分子和细胞机制及其对癌症进展和治疗反应的影响。我们还全面综述了在胃肠道癌症背景下将慢性炎症与癌症联系起来的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2f5/11955699/c46d15bf790c/fonc-15-1564572-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2f5/11955699/9fa25edd1705/fonc-15-1564572-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2f5/11955699/66742ebadf52/fonc-15-1564572-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2f5/11955699/c46d15bf790c/fonc-15-1564572-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2f5/11955699/9fa25edd1705/fonc-15-1564572-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2f5/11955699/66742ebadf52/fonc-15-1564572-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2f5/11955699/c46d15bf790c/fonc-15-1564572-g003.jpg

相似文献

1
Inflammation and cancer: molecular mechanisms and clinical consequences.炎症与癌症:分子机制及临床后果
Front Oncol. 2025 Mar 17;15:1564572. doi: 10.3389/fonc.2025.1564572. eCollection 2025.
2
Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.癌症相关成纤维细胞在肝细胞癌进展和治疗中的新作用。
Int J Mol Sci. 2023 Feb 15;24(4):3941. doi: 10.3390/ijms24043941.
3
Inflammation and Cancer: Triggers, Mechanisms, and Consequences.炎症与癌症:触发因素、机制与后果。
Immunity. 2019 Jul 16;51(1):27-41. doi: 10.1016/j.immuni.2019.06.025.
4
Unveiling the link between chronic inflammation and cancer.揭示慢性炎症与癌症之间的联系。
Metabol Open. 2025 Jan 9;25:100347. doi: 10.1016/j.metop.2025.100347. eCollection 2025 Mar.
5
The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis.炎症在癌症中的作用:肿瘤起始、进展和转移的机制
Cells. 2025 Mar 25;14(7):488. doi: 10.3390/cells14070488.
6
Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.肿瘤微环境与一氧化氮:概念与机制。
Adv Exp Med Biol. 2020;1277:143-158. doi: 10.1007/978-3-030-50224-9_10.
7
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.肿瘤微环境中癌症相关成纤维细胞与免疫细胞的串扰:新发现与未来展望。
Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1.
8
The Microenvironment of Lung Cancer and Therapeutic Implications.肺癌的微环境及其治疗意义
Adv Exp Med Biol. 2016;890:75-110. doi: 10.1007/978-3-319-24932-2_5.
9
Targeting the microenvironment in solid tumors.靶向实体瘤的微环境。
Cancer Treat Rev. 2018 Apr;65:22-32. doi: 10.1016/j.ctrv.2018.02.004. Epub 2018 Feb 22.
10
Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment.肿瘤微环境中炎症、固有免疫细胞及信号通路的相互作用三联体
Front Pharmacol. 2023 Aug 17;14:1255727. doi: 10.3389/fphar.2023.1255727. eCollection 2023.

引用本文的文献

1
Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes.他汀类药物在炎症和癌症治疗中的分子及免疫调节机制,重点关注核因子κB、NLRP3炎性小体和细胞因子调节轴
Int J Mol Sci. 2025 Aug 29;26(17):8429. doi: 10.3390/ijms26178429.
2
Exploring the aftermath of hematopoietic cell transplantation: 18-year insights into post-transplant neoplasms.探索造血细胞移植的后果:对移植后肿瘤的18年洞察
Front Oncol. 2025 Jul 22;15:1589755. doi: 10.3389/fonc.2025.1589755. eCollection 2025.
3
The Role of Diet and Nutrition in Cancer Development and Management: From Molecular Mechanisms to Personalized Interventions.

本文引用的文献

1
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors.细胞死亡的免疫原性与免疫检查点抑制剂的癌症免疫治疗
Cell Mol Immunol. 2025 Jan;22(1):24-39. doi: 10.1038/s41423-024-01245-8. Epub 2024 Dec 10.
2
Clinical functional proteomics of intercellular signalling in pancreatic cancer.胰腺癌细胞间信号传导的临床功能蛋白质组学
Nature. 2025 Jan;637(8046):726-735. doi: 10.1038/s41586-024-08225-y. Epub 2024 Nov 13.
3
MicroRNA-107 - a small RNA with a big impact on cytokinesis in hepatocellular carcinoma.
饮食与营养在癌症发生发展及管理中的作用:从分子机制到个性化干预
Foods. 2025 May 18;14(10):1788. doi: 10.3390/foods14101788.
微小RNA-107——一种对肝细胞癌胞质分裂有重大影响的小RNA。
J Hepatol. 2025 Mar;82(3):414-416. doi: 10.1016/j.jhep.2024.09.045. Epub 2024 Oct 11.
4
Natural Killer cells at the frontline in the fight against cancer.自然杀伤细胞在抗击癌症的第一线。
Cell Death Dis. 2024 Aug 23;15(8):614. doi: 10.1038/s41419-024-06976-0.
5
Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects.肝细胞癌中的程序性细胞死亡:机制与治疗前景
Cell Death Discov. 2024 Aug 8;10(1):356. doi: 10.1038/s41420-024-02116-x.
6
Hypoxia and inflammation induce synergistic transcriptome turnover in macrophages.缺氧和炎症诱导巨噬细胞中的协同转录组翻转。
Cell Rep. 2024 Jul 23;43(7):114452. doi: 10.1016/j.celrep.2024.114452. Epub 2024 Jul 4.
7
Immunotherapy for hepatocellular carcinoma: The next evolution in expanding access to liver transplantation.肝细胞癌的免疫治疗:扩大肝移植机会的下一个演进。
J Hepatol. 2024 Oct;81(4):743-755. doi: 10.1016/j.jhep.2024.05.037. Epub 2024 Jun 5.
8
Inflammation and cancer: friend or foe?炎症与癌症:是友还是敌?
Front Pharmacol. 2024 May 10;15:1385479. doi: 10.3389/fphar.2024.1385479. eCollection 2024.
9
Emerging Trends in Gastrointestinal Cancer Targeted Therapies: Harnessing Tumor Microenvironment, Immune Factors, and Metabolomics Insights.胃肠道癌靶向治疗的新兴趋势:利用肿瘤微环境、免疫因素和代谢组学见解。
Gastroenterology. 2024 Oct;167(5):867-884. doi: 10.1053/j.gastro.2024.05.005. Epub 2024 May 15.
10
A temporal perspective for tumor-associated macrophage identities and functions.从时间角度看肿瘤相关巨噬细胞的特征和功能。
Cancer Cell. 2024 May 13;42(5):747-758. doi: 10.1016/j.ccell.2024.04.002. Epub 2024 Apr 25.